Candel Therapeutics Inc (CADL)
11.56
-1.14
(-8.98%)
USD |
NASDAQ |
May 17, 16:00
11.51
-0.05
(-0.43%)
After-Hours: 20:00
Candel Therapeutics 1 Year Total Returns (Daily): 637.2% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 637.2% |
| May 16, 2024 | 703.8% |
| May 15, 2024 | 775.0% |
| May 14, 2024 | 590.3% |
| May 13, 2024 | 558.1% |
| May 10, 2024 | 423.6% |
| May 09, 2024 | 473.0% |
| May 08, 2024 | 560.4% |
| May 07, 2024 | 481.2% |
| May 06, 2024 | 436.4% |
| May 03, 2024 | 467.3% |
| May 02, 2024 | 436.9% |
| May 01, 2024 | 486.8% |
| April 30, 2024 | 446.5% |
| April 29, 2024 | 396.9% |
| April 26, 2024 | 376.9% |
| April 25, 2024 | 359.3% |
| April 24, 2024 | 348.1% |
| April 23, 2024 | 322.1% |
| April 22, 2024 | 295.7% |
| April 19, 2024 | 316.9% |
| April 18, 2024 | 261.6% |
| April 17, 2024 | 221.9% |
| April 16, 2024 | 314.8% |
| April 15, 2024 | 309.9% |
| Date | Value |
|---|---|
| April 12, 2024 | 382.6% |
| April 11, 2024 | 431.4% |
| April 10, 2024 | 264.3% |
| April 09, 2024 | 266.2% |
| April 08, 2024 | 362.6% |
| April 05, 2024 | 367.6% |
| April 04, 2024 | 357.1% |
| April 03, 2024 | 19.15% |
| April 02, 2024 | 25.19% |
| April 01, 2024 | 29.63% |
| March 28, 2024 | 12.86% |
| March 27, 2024 | 10.00% |
| March 26, 2024 | 0.00% |
| March 25, 2024 | 2.01% |
| March 22, 2024 | 2.04% |
| March 21, 2024 | 2.84% |
| March 20, 2024 | 1.35% |
| March 19, 2024 | 4.90% |
| March 18, 2024 | -2.10% |
| March 15, 2024 | 0.00% |
| March 14, 2024 | 4.70% |
| March 13, 2024 | 0.00% |
| March 12, 2024 | -0.62% |
| March 11, 2024 | 3.70% |
| March 08, 2024 | -21.50% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.58%
Minimum
Nov 04 2022
775.0%
Maximum
May 15 2024
-22.53%
Average
-59.09%
Median
1 Year Total Returns (Daily) Benchmarks
| Allurion Technologies Inc | -- |
| AngioDynamics Inc | -36.75% |
| Eliem Therapeutics Inc | 191.5% |
| Macrogenics Inc | -28.44% |
| GlycoMimetics Inc | -85.32% |